Product References
Network pharmacology integrated with experimental validation revealed potential molecular mechanisms of Camellia nitidissima C. W. Chi in the treatment of lung cancer.
Journal of ethnopharmacology
Zhou A,Zhou C,Wang D,Qian M,Huang L
Thu Oct 05 00:00:00 UTC 2023
Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid sphingomyelinase.
Molecular therapy : the journal of the American Society of Gene Therapy
Wang Y,Chen YY,Gao GB,Zheng YH,Yu NN,Ouyang L,Gao X,Li N,Wen SY,Huang S,Zhao Q,Liu L,Cao M,Zhang S,Zhang J,He QY
Wed Jul 05 00:00:00 UTC 2023
ADAM12 promotes gemcitabine resistance by activating EGFR signaling pathway and induces EMT in bladder cancer.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Wang R,Gao D,Chen C,Fan G,Cheng H,Tao Y,Lu J,Tian J,Wang Y,Wang Z
Mon May 01 00:00:00 UTC 2023
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
Journal of experimental & clinical cancer research : CR
Huang Z,Rui X,Yi C,Chen Y,Chen R,Liang Y,Wang Y,Yao W,Xu X,Huang Z
Sat Mar 11 00:00:00 UTC 2023
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
Journal of experimental & clinical cancer research : CR
Huang Z,Rui X,Yi C,Chen Y,Chen R,Liang Y,Wang Y,Yao W,Xu X,Huang Z
Sat Mar 11 00:00:00 UTC 2023
Silencing LCN2 suppresses oral squamous cell carcinoma progression by reducing EGFR signal activation and recycling.
Journal of experimental & clinical cancer research : CR
Huang Z,Rui X,Yi C,Chen Y,Chen R,Liang Y,Wang Y,Yao W,Xu X,Huang Z
Sat Mar 11 00:00:00 UTC 2023
Combination of DNA Damage, Autophagy, and ERK Inhibition: Novel Evodiamine-Inspired Multi-Action Pt(IV) Prodrugs with High-Efficiency and Low-Toxicity Antitumor Activity.
Journal of medicinal chemistry
Liu XM,Li Z,Xie XR,Wang JQ,Qiao X,Qiao X,Xie CZ,Xu JY
Thu Feb 09 00:00:00 UTC 2023
JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
International journal of molecular sciences
Ding K,Jiang X,Wang Z,Zou L,Cui J,Li X,Shu C,Li A,Zhou J
Mon May 15 00:00:00 UTC 2023
JAC4 Inhibits EGFR-Driven Lung Adenocarcinoma Growth and Metastasis through CTBP1-Mediated JWA/AMPK/NEDD4L/EGFR Axis.
International journal of molecular sciences
Ding K,Jiang X,Wang Z,Zou L,Cui J,Li X,Shu C,Li A,Zhou J
Mon May 15 00:00:00 UTC 2023
Hepatitis B virus X protein increases LASP1 SUMOylation to stabilize HER2 and facilitate hepatocarcinogenesis.
International journal of biological macromolecules
You H,Yuan D,Li Q,Zhang N,Kong D,Yu T,Liu X,Liu X,Zhou R,Kong F,Zheng K,Tang R
Tue Jan 31 00:00:00 UTC 2023
A Wnt/β-catenin signaling inhibitor, IMU1003, suppresses the emergence of osimertinib-resistant colonies from gefitinib-resistant non-small cell lung cancer cells.
Biochemical and biophysical research communications
Katagiri H,Yonezawa H,Shitamura S,Sugawara A,Kawano T,Maemondo M,Nishiya N
Sun Feb 19 00:00:00 UTC 2023
The location of estrogen receptor variant ER-α36 is associated with the invasion of glioblastoma.
Steroids
Li H,Ge N,Guan X,Han C,Li Y,Shen L,Chen M,Zhang B,Qu C,Zou W
Thu Jun 01 00:00:00 UTC 2023
The GBM Tumor Microenvironment as a Modulator of Therapy Response: ADAM8 Causes Tumor Infiltration of Tams through HB-EGF/EGFR-Mediated CCL2 Expression and Overcomes TMZ Chemosensitization in Glioblastoma.
Cancers
Liu X,Huang Y,Qi Y,Wu S,Hu F,Wang J,Shu K,Zhang H,Bartsch JW,Nimsky C,Dong F,Lei T
Fri Oct 07 00:00:00 UTC 2022
Estrogen receptor variant ER-α36 facilitates estrogen signaling via EGFR in glioblastoma.
Cell biology international
Qu C,Wang C,Li H,Li Y,Han C,Tao X,Guan X,Zhang Y,Chen M,Liu J,Zou W
Tue Nov 01 00:00:00 UTC 2022
Estrogen receptor variant ER-α36 facilitates estrogen signaling via EGFR in glioblastoma.
Cell biology international
Qu C,Wang C,Li H,Li Y,Han C,Tao X,Guan X,Zhang Y,Chen M,Liu J,Zou W
Tue Nov 01 00:00:00 UTC 2022
Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation.
Frontiers in pharmacology
Liu M,Hu T,Gou W,Chang H,Li Y,Li Y,Zuo D,Hou W,Jiao S
Fri Feb 17 00:00:00 UTC 2023
Co-Targeting ErbB Receptors and the PI3K/AKT Axis in Androgen-Independent Taxane-Sensitive and Taxane-Resistant Human Prostate Cancer Cells.
Cancers
Adediran S,Wang L,Khan MA,Guang W,Fan X,Dan H,Qi J,Jay SM,Carrier F,Hussain A
Fri Sep 23 00:00:00 UTC 2022
Discovery of a covalent inhibitor of heat shock protein 90 with antitumor activity that blocks the co-chaperone binding via C-terminal modification.
Cell chemical biology
Li L,Chen N,Xia D,Xu S,Dai W,Tong Y,Wang L,Jiang Z,You Q,Xu X
Thu Oct 21 00:00:00 UTC 2021
Evodiamine Inhibits Gastric Cancer Cell Proliferation via PTEN-Mediated EGF/PI3K Signaling Pathway.
Evidence-based complementary and alternative medicine : eCAM
Yang R,Wen J,Yang T,Dai C,Zhao Y
Thu Apr 28 00:00:00 UTC 2022